Have a feature idea you'd love to see implemented?
Let us know!
NARI Inari Medical Inc
Price (delayed)
$49.07
Market cap
$2.87B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.35
Enterprise value
$2.86B
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive,
Highlights
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter
NARI's gross profit is up by 20% YoY and by 4.5% QoQ
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter
The quick ratio has plunged by 79% YoY and by 4.3% from the previous quarter
NARI's net income is down by 38% since the previous quarter
Key stats
What are the main financial stats of NARI
Market
Valuations
Earnings
Shares outstanding
58.54M
Market cap
$2.87B
Enterprise value
$2.86B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.58
Price to sales (P/S)
4.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.99
Revenue
$574.5M
EBIT
-$53.05M
EBITDA
-$34.87M
Free cash flow
$1.58M
Per share
Balance sheet
Liquidity
EPS
-$1.35
Free cash flow per share
$0.03
Book value per share
$7.46
Revenue per share
$9.84
TBVPS
$5.83
Total assets
$697.24M
Total liabilities
$262.48M
Debt
$32.72M
Equity
$434.76M
Working capital
$114.61M
Debt to equity
0.08
Current ratio
1.77
Quick ratio
1.32
Net debt/EBITDA
0.24
Margins
Efficiency
Dividend
EBITDA margin
-6.1%
Gross margin
86.8%
Net margin
-13.7%
Operating margin
-7.6%
Return on assets
-11.6%
Return on equity
-17.8%
Return on invested capital
-28.6%
Return on capital employed
-9.7%
Return on sales
-9.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NARI stock price
How has the Inari Medical stock price performed over time
Intraday
-0.22%
1 week
11.24%
1 month
18.99%
1 year
-15.89%
YTD
-24.41%
QTD
18.99%
Financial performance
How have Inari Medical's revenue and profit performed over time
Revenue
$574.5M
Gross profit
$498.76M
Operating income
-$43.88M
Net income
-$78.58M
Gross margin
86.8%
Net margin
-13.7%
NARI's net income is down by 38% since the previous quarter
Inari Medical's net margin has decreased by 32% from the previous quarter
The operating income has contracted by 26% from the previous quarter
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter
Growth
What is Inari Medical's growth rate over time
Valuation
What is Inari Medical stock price valuation
P/E
N/A
P/B
6.58
P/S
4.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.99
The EPS has declined by 38% since the previous quarter
The price to book (P/B) is 46% lower than the 5-year quarterly average of 12.2
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter
The P/S is 63% below the 5-year quarterly average of 13.4 and 9% below the last 4 quarters average of 5.5
The revenue rose by 22% year-on-year and by 4.9% since the previous quarter
Efficiency
How efficient is Inari Medical business performance
NARI's return on invested capital has dropped by 103% since the previous quarter
The return on sales has declined by 44% since the previous quarter
The return on equity has declined by 39% since the previous quarter
The company's return on assets fell by 30% QoQ
Dividends
What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NARI.
Financial health
How did Inari Medical financials performed over time
The total assets is 166% greater than the total liabilities
The company's total liabilities has surged by 171% YoY and by 5% QoQ
The quick ratio has plunged by 79% YoY and by 4.3% from the previous quarter
Inari Medical's debt is 92% less than its equity
NARI's debt to equity is up by 14% YoY
The equity is down by 3.8% year-on-year but it is up by 2.6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.